| 1. |
Hypertension treatment recommendationsrevision needed? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 2-2
&NA;,
Preview
|
PDF (866KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 2. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 3-3
&NA;,
Preview
|
PDF (732KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 3. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 4-4
&NA;,
Preview
|
PDF (744KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 5-5
&NA;,
Preview
|
PDF (775KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 5. |
Infectious disease news from the 4th annual ISPOR meetingArlington, Virginia, US May 1999 |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 6-7
&NA;,
Preview
|
PDF (1675KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 6. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 8-8
&NA;,
Preview
|
PDF (795KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 7. |
A senescence gene therapy for rheumatoid arthritis? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 9-9
&NA;,
Preview
|
PDF (748KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 8. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 10-10
&NA;,
Preview
|
PDF (838KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 9. |
Great news for brittle bones |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 11-12
Charles Bankhead,
Preview
|
PDF (1628KB)
|
|
摘要:
Results of a much-anticipated comparison of 2 competing osteoporosis therapies show a significant advantage for Merck & Co.'s bisphosphonate agent alendronic acid [‘Fosamax’] over Novartis' intranasal calcitonin [‘Miacalcin’] in postmenopausal women with osteoporosis. Treatment with alendronic acid led to greater increases in bone mineral density (BMD) in the spine, femoral neck and trochanter, compared with calcitonin. The agents had similar tolerability; in addition, the incidence of adverse events in both active therapy groups was similar to that seen in placebo recipients, as reported at the 81st Annual Meeting of the Endocrine Society [San Diego, US; June 1999].
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 10. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1198,
1999,
Page 12-12
&NA;,
Preview
|
PDF (798KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
首页
